Drug resistance mutation profiles of the drug-naïve and first-line regimen-treated HIV-1-infected population of Suzhou, China-Reference-Cited by-同舟云学术

Drug resistance mutation profiles of the drug-naïve and first-line regimen-treated HIV-1-infected population of Suzhou, China

Published:2017-08 Issue:4 Volume:32 Page:271-279
ISSN:1674-0769
Container-title:Virologica Sinica
language:en
Short-container-title:Virol. Sin.

Author:

Li Tingting,Qian Feng,Yuan Ting,Xu Weilu,Zhu Li,Huang Jinlong,Wang Haiyan,Zhu Yueping,Wang Yinling,Li Xiaohong,Gu Saihong,Tan Zhuqing,Chen Hui,Luo Xiangrong,Zhu Wei,Lu Wenjuan,Xu Ping,Li Ming,Chen Yuying,Gao Yong,Yang Rongge,Zhu Chuanwu^ORCID,Sun Binlian^ORCID

Publisher

Elsevier BV

Subject

Virology,Molecular Medicine,Immunology

Link

http://link.springer.com/article/10.1007/s12250-017-4002-y/fulltext.html

Reference36 articles.

1. Barbour JD, Hecht FM, Wrin T, Liegler TJ, Ramstead CA, Busch MP, Segal MR, Petropoulos CJ, Grant RM. 2004. Persistence of primary drug resistance among recently HIV-1 infected adults. AIDS, 18: 1683–1689.

2. Boyd MA, Cooper DA. 2007. Second-line combination antiretroviral therapy in resource-limited settings: facing the challenges through clinical research. AIDS, 21(Suppl 4): S55–S63.

3. Chen X, Ye M, Zhou YH, Liu FL, Duo L, Li H, Pang W, Zheng YT. 2015. High seroprevalence of toxoplasma gondii and HIV-1 co-infection among drug users in Yunnan province, southwest China. Sci China Life Sci, 59: 857–859.

4. Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, Hakim JG, Kumwenda J, Grinsztejn B, Pilotto JH, Godbole SV, Chariyalertsak S, Santos BR, Mayer KH, Hoffman IF, Eshleman SH, Piwowar-Manning E, Cottle L, Zhang XC, Makhema J, Mills LA, Panchia R, Faesen S, Eron J, Gallant J, Havlir D, Swindells S, Elharrar V, Burns D, Taha TE, Nielsen-Saines K, Celentano DD, Essex M, Hudelson SE, Redd AD, Fleming TR. 2016. Antiretroviral Therapy for the Prevention of HIV-1 Transmission. N Engl J Med, 375: 830–839.

5. Cohen MS, Smith MK, Muessig KE, Hallett TB, Powers KA, Kashuba AD. 2013. Antiretroviral treatment of HIV-1 prevents transmission of HIV-1: where do we go from here?. Lancet, 382: 1515–1524.

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Proposal of pharmacophore model for HIV reverse transcriptase inhibitors: Combined mutational effect analysis, molecular dynamics, molecular docking and pharmacophore modeling study;International Journal of Immunopathology and Pharmacology;2024-01

2. Increasing trends of overweight and obesity in treatment-naive people living with HIV in Shenzhen from 2014 to 2020: an emerging health concern;Frontiers in Public Health;2023-10-10

3. Prevalence of Drug Resistance and Genetic Transmission Networks Among Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome Patients with Antiretroviral Therapy Failure in Guangxi, China;AIDS Research and Human Retroviruses;2022-10-01

4. Mutation patterns, cross resistance and virological failure among HIV type-1 patients in Alexandria, Egypt;Future Virology;2022-07

5. The Prevalence and Related Effects of HIV Drug-Resistant Strains Against Antiretroviral Therapy in China;Infectious Microbes and Diseases;2022-05-17